Page 34 - May 2018 Disruption Report Flip Book

EXPONENTIAL CHANGE IN 2018 JANMUAAYRY20128018
We will also make more progress in understanding questions of trust, fairness, and justice in algorithmic systems. Sensible boards, prompted by legislators, regulators, and activists will make ethical AI a top-table issue.
8. Cryptotechnologies will become more important and start to demonstrate their utility. In 2018, the activity in decentralized applications and protocols based on tokenization will increase. Below the speculative froth are sober-minded teams coming together to tackle real problems using the unique attributes of blockchain technologies.
We’ll see AI developers increasingly experiment with the fruitful combination of AI and blockchain. These areas include how to build a data commons to incentivize the sharing of data, allow the sharing of models, and using blockchains and smart contracts for individual AIs to mediate their machine-to-machine interactions.
9. Sordid revelations in crypto-speculation will be outweighed by the wall of money entering the assets class. Asinine press releases, speculative investors, and shady enablers get out into the market much faster than the technology can become useful. This lurid funk will obscure technology progress as more out-and-out frauds are met with regulatory intervention and commentators watch speculators from the safety of their schadenfreude pulpits.
It may not matter, because every discussion about cryptoassets increases their actuality in the market. This will see an increasing range of products for institutional investors and, crucially, high-net-worth investors wanting to get exposure to this asset class. This speculative bubble might pop, or it might not.
10. KITT, the car from Knight Rider, will remain the gold standard for autonomous vehicles. Autonomous vehicle pilots will become increasingly ambitious, but the real-world hurdles will still take time to navigate, even with friendly city regulators. None will ship to the public in 2018.
11. Health care becomes increasingly interesting for entrepreneurs. Why? The first FDA- approved gene therapy is in the market. More approvals are likely to follow. CRISPR is likely to appear in human trials this year, too.
Separately, the success of applying deep-learning techniques to electronic health records, low-quality consumer tracking data, and medical images will create confidence in producing breakthrough applications.
© 2018 by Canfield Press, LLC. All rights reserved. www.canfieldpress.com
34